Year None20222021202020192018201720162015201420132012 09.07.2022 Iveric Bio to Present at Upcoming Investor Conferences 09.06.2022 Iveric Bio Announces Positive Topline Data from Zimura® GATHER2 Phase 3 Clinical Trial in Geographic Atrophy 09.02.2022 Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 08.10.2022 Iveric Bio to Participate in the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference 08.03.2022 Iveric Bio to Present at the Wedbush PacGrow Healthcare Conference 2022 08.02.2022 Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 07.26.2022 Iveric Bio Reports Second Quarter 2022 Operational Highlights and Financial Results 07.26.2022 Iveric Bio Announces Agreement for Up to $250 Million in Non-Dilutive Debt Financing with Hercules Capital and Silicon Valley Bank 07.21.2022 Iveric Bio to Report Second Quarter 2022 Financial Results and Host Conference Call on Tuesday, July 26, 2022 07.16.2022 Iveric Bio Announces Post-Hoc Analysis from GATHER1 Clinical Trial of Zimura® at American Society of Retina Specialists Meeting Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
